No Ban On Transvaginal Mesh Devices So Far By FDA
No Ban On Transvaginal Mesh Devices So Far By FDA
Introduction
The FDA has shown no signs or indications regarding any ban on transvaginal mesh devices used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) with the news pouring in about a recommended ban requested by the National Institute for Health and Care Excellence (NICE) in the U.K.
NICE requested the ban indicated for the treatment of POP and not SUI and expects a virtual ban as the news spreads.
Although thousands of transvaginal lawsuits have been filed in the U.S. since 2008, with mixed verdicts announced for both parties, and manufacturers settling a significant number of claims, the FDA has no intention of considering a ban. The agency did reclassify the device in 2016 as a Class III (high risk) product for the treatment of POP, making them ineligible for the 510(k) clearance program.
Comments
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Categories: Opioids
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
Categories: Philips CPAP/BiPAP/ASV Sleep Apnea Machines
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Categories: Opioids
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…